Carbylan Therapeutics

Carbylan Therapeutics (formerly Carbylan BioSurgery, Inc.), established in 2004, is currently headquartered in Palo Alto, California. It is a clinical-stage specialty pharmaceutical company focused on the development and commercialization of proprietary combination therapies.On June 15, 2016, it was acquired by KalVista Pharmaceuticals.